GI CONNECT has summarised the highlights from the ASCO GI 2020 meeting for you. Dr Yu Sunakawa (Japan) provides the highlights on cancer of the liver, small intestine and pancreas tract.
Oncology
GI CONNECT Update from ASCO GI 2020
Episode 2: Cancers of the liver, small intestine and pancreas tract
Publication Date
Sep 2021
Dr Yu Sunakawa is a medical oncologist at St. Marianna University, Japan and previously worked as an instructor at Showa University Northern Yokohama Hospital in Yokohama, Japan. He also completed postdoctoral research fellowship training at University of Southern California/Norris Comprehensive Cancer Center in United States. In 2011, Dr Sunakawa received the board certification of the Japanese Society of Medical Oncology. Dr Sunakawa’s research interests are the identification and determination of molecular markers in cancerous tissues or blood that could predict cancer risk and clinical outcome in gastrointestinal cancer. He is also focusing on research regarding tumour immunity and received a Merit Award from the American Society of Clinical Oncology in 2014, for the research of genetic variations in immune checkpoint-related genes.
Assoc. Prof. Yu Sunakawa has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
Bayer, Bristol-Myers, Biopharma, Chugai Pharm, Daiichi-Sankyo, Gurdant, Lilly, Ono Pharm, Sanofi, Sysmex, Takeda and Tahio Pharm.
Download slides PDF 
Programme summary
Duration 5 MIN- Downloadable resources Yes
-
Download slides PDF
-
Language(s)
Duration 
Language(s)
Other episodes in this series
Episode 1: Cancers of the lower GI tract
GI CONNECT Update from ASCO GI 2020
Episode 2: Cancers of the liver, small intestine and pancreas tract Current Episode
Episode 3: Cancers of the upper GI tract
GI CONNECT Update from ASCO 2020
Episode 4: GI cancer highlights
Share this programme
Brought to you by
GI CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Bayer, Ipsen, BeiGene Europe and Pierre Fabre.
Meet the expertsOther programmes of interest
Other
Episode
2
of 2
Oncology
Optimising samples for biomarker testing in lung, prostate and gastric cancer
Recommendations for best practice
Experts
Dr Alexander Wyatt, Prof. Frédéric BibeauEndorsed by
-
Downloadable
Resources -
5 MIN
-
Aug 2024
Downloadable 
5 MIN
Aug 2024 
Publication
Oncology
Advancing HCC management in Asia: insights from patients and HCPs
Paper published in Journal of Gastrointestinal Cancer
Experts
Prof. Chee-Kiat Tan-
Downloadable
Resources -
15 MIN
-
Jul 2024
Other
Oncology
Come and visit us in Barcelona at ESMO 2024!
Get your free professional profile photos taken with us at Booth 507
-
1 MIN
-
Jul 2024
Micro learning
Oncology Endocrinology Rare diseases
Tools for optimising treatment & management of advanced NETs
Maximising outcomes for patients with advanced neuroendocrine tumours
Experts
Prof. Emily Bergsland, Asst Prof. Louis de MestierEndorsed by
-
Downloadable
Resources -
4 MIN
-
Jul 2024
Video
Oncology
The evolving role of liquid biopsy in biomarker testing
Clinical application of liquid biopsy, and how it applies to NSCLC, breast and colorectal cancer
Experts
Assoc. Prof. Umberto Malapelle-
Downloadable
Resources -
5 MIN
-
Jul 2024
Interactive patient case
Oncology
Advanced renal cell carcinoma: Managing a long-term durable response
Maximising outcomes for patients with advanced RCC
Experts
Prof. Michael StaehlerEndorsed by
-
MIN
-
Jun 2024
